Pgen stock forecast updates point to regulatory

PGEN stock forecast updates point to regulatory developments in the gene therapy space, which could add upside risk if FDA guidance becomes favorable. Tracking sector ETFs may provide early signals of broader trend changes. Overall PGEN ranks 9th on our list of the biotech stocks that are skyrocketing so far in 2025. While we acknowledge the potential of PGEN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PGEN but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock . To see Spark’s full report on PGEN stock, click here . Chart watchers note PGEN stock forecast patterns resembling cup-and-handle formations, widely considered bullish. A sustained break above $2.00 could trigger momentum buying among swing traders.